Organon & Co | Passività Correnti





Passività Correnti Cambiamento Data
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Celltrion KRW 4.01T 343.96B 2025-09
Cspc Pharmaceutical CNY 10.11B 478.47M 2025-06
Dianthus Therapeutics USD 23.86M 3.76M 2025-09
Divis Laboratories Ltd INR 17.28B 2.76B 2025-09
Gilead Sciences USD 12.3B 1.11B 2025-09
Glaxosmithkline GBP 28.68B 8.3B 2025-09
Kangmei Pharma CNY 5.81B 57.93M 2025-09
Knight Therapeutics CAD 118.15M 12.32M 2024-09
Laboratorios Farma EUR 199.84M 121.75M 2023-12
Malin Corporation EUR 1000K 500K 2024-12
Medical Developments International AUD 7.82M 1.45M 2025-06
Merck USD 28.63B 2.59B 2025-09
Neuren Pharmaceuticals AUD 7.92M 37.84M 2025-06
Novartis USD 32B 286M 2025-09
Organigram Holdings CAD 126.16M 18.88M 2025-09
Organon & Co USD 2.68B 117M 2025-09
Pharma Mar EUR 88.93M 1.15M 2025-09
Qiagen NV USD 973.4M 154.91M 2025-09
Sartorius EUR 1.81B 254.3M 2025-09
Sino Biopharmaceutical CNY 24.85B 5.29B 2025-06
Tilray USD 280.3M 18.13M 2025-03


Organon & Co Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.